Deep TMS News - Get The Latest News On BrainsWay's Deep TMS

News & Events

August 10, 2022

BrainsWay Reports Second Quarter 2022 Financial Results and Operational Highlights

Revenue Growth of 14% Year-over-Year in Q2 2022 Conference call to be held today, August 10, 2022, at...

July 27, 2022

BrainsWay to Report Second Quarter Financial Results on August 10, 2022

BURLINGTON, Mass. and JERUSALEM, July 27, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

June 28, 2022

BrainsWay Announces Insurance Coverage by Israeli Ministry of Health for the Treatment of Depression

The Company’s Groundbreaking Deep TMS™ Treatment is Included in Israel’s Health Basket of Essential...

June 23, 2022

BrainsWay Donates $10,000 to Mental Health America in Support of Mental Health Awareness Month

BURLINGTON, Mass. and JERUSALEM, Israel, June 23, 2022 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

June 22, 2022

BrainsWay to Present at the H.C. Wainwright 1st Annual Mental Health Conference

BURLINGTON, Mass. and JERUSALEM, June 22, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

June 21, 2022

BrainsWay Announces Positive OCD Coverage Policy from Blue Cross Blue Shield® (BCBS) Licensee Highmark BCBS for Deep TMS™

Highmark BCBS Covers 6.8 Million Members in Four States BURLINGTON, Mass. and JERUSALEM, June 21, 2022...

May 11, 2022

BrainsWay Reports First Quarter 2022 Financial Results and Operational Highlights

Revenue Growth of 30% Year-over-Year in Q1 2022 Conference call to be held today, May 11, 2022, at 8:30...

May 9, 2022

BrainsWay Appoints Eric Hirt as Vice President of U.S. Sales

Veteran Medical Device Industry Sales and Marketing Executive Has Over 20 Years of Experience BURLINGTON,...

May 4, 2022

BrainsWay to Present Expanded Post-Marketing Clinical Research for Major Depressive Disorder at Clinical TMS Society

Additional presentations will highlight the utility of Deep TMS™ in Smoking Addiction and OCD BURLINGTON,...

May 2, 2022

BrainsWay Launches #DontMissAnotherMoment Social Media Campaign to Promote Mental Health Awareness Month

BrainsWay will donate $5 per share, $2 per comment, and $1 per like to support the work of Mental Health...

April 27, 2022

BrainsWay to Report First Quarter Financial Results on May 11, 2022

BURLINGTON, Mass. and JERUSALEM, April 27, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

March 28, 2022

BrainsWay Appoints Dr. Joachim Seidel as Vice President of Corporate Development and Strategy

Dr. Seidel has more than 20 years of experience in the medical device industry BURLINGTON, Mass. and...

March 15, 2022

BrainsWay to Host Key Opinion Leader Webinar on Deep TMS™ Therapy for Treating Anxious Depression

BURLINGTON, Mass. and JERUSALEM, March 15, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

March 9, 2022

BrainsWay Reports Fourth Quarter and Full-Year 2021 Financial Results and Operational Highlights

Revenue Growth of 34% in 2021, with Record Quarterly and Annual Revenues Continued Progress in Expanding...

March 1, 2022

BrainsWay to Present at the 32nd Annual Oppenheimer Healthcare Conference

BURLINGTON, Mass. and JERUSALEM, March 01, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

February 28, 2022

BrainsWay to Report Fourth Quarter and Full Year 2021 Financial Results on March 9, 2022

BURLINGTON, Mass. and JERUSALEM, Feb. 28, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

February 23, 2022

BrainsWay Announces Publication of Results Demonstrating Efficacy of Deep TMS™ in Treating Anxiety Symptoms Comorbid to Depression

Results Distinguish Deep TMS as More Effective in Subjects with Higher Anxiety Symptoms, Long Considered...

February 1, 2022

BrainsWay to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

BURLINGTON, Mass. and JERUSALEM, February 1, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...